{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:41:41Z","timestamp":1778942501407,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["MD007593"],"award-info":[{"award-number":["MD007593"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["DA029506"],"award-info":[{"award-number":["DA029506"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["U54 RR026140"],"award-info":[{"award-number":["U54 RR026140"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA033892"],"award-info":[{"award-number":["DA033892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA30896"],"award-info":[{"award-number":["DA30896"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA024558"],"award-info":[{"award-number":["DA024558"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ajpath.2013.12.004","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T05:45:18Z","timestamp":1391233518000},"page":"927-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cocaine Enhances HIV-1\u2013Induced CD4+ T-Cell Apoptosis"],"prefix":"10.1016","volume":"184","author":[{"given":"Jui","family":"Pandhare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amma B.","family":"Addai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinmay K.","family":"Mantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros A.","family":"Kalams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandravanu","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.12.004_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States","volume":"194","author":"Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2013.12.004_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jsat.2011.01.001","article-title":"Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy","volume":"40","author":"Kipp","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ajpath.2013.12.004_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e3181900129","article-title":"Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users","volume":"50","author":"Baum","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajpath.2013.12.004_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e3282f3cc21","article-title":"Illicit drug use and HIV treatment outcomes in a US cohort","volume":"22","author":"Cofrancesco","year":"2008","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2013.12.004_bib5","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1089\/apc.2007.9985","article-title":"Type and pattern of illicit drug use and access to health care services for HIV-infected people","volume":"21","author":"Sohler","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00042560-200107010-00015","article-title":"Cofactors for HIV disease progression in a cohort of homosexual and bisexual men","volume":"27","author":"Vittinghoff","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajpath.2013.12.004_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/323201","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring","volume":"33","author":"Arnsten","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2013.12.004_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users","volume":"17","author":"Arnsten","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-199902040-00014","article-title":"A prospective study of HIV disease progression in female and male drug users","volume":"13","author":"Webber","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00042560-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajpath.2013.12.004_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/aje\/kwj059","article-title":"Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy","volume":"163","author":"Lucas","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10461-006-9152-0","article-title":"Drug use and medication adherence among HIV-1 infected individuals","volume":"11","author":"Hinkin","year":"2007","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajpath.2013.12.004_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.drugalcdep.2007.11.010","article-title":"Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men","volume":"94","author":"Chao","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajpath.2013.12.004_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042560-199903010-00010","article-title":"Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies: AIDS Link to Intravenous Experiences: Italian Seroconversion Study","volume":"20","author":"Pezzotti","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00126334-200304150-00009","article-title":"Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use","volume":"32","author":"Palepu","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajpath.2013.12.004_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09540121.2012.687814","article-title":"Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits","volume":"25","author":"Rasbach","year":"2013","journal-title":"AIDS Care"},{"key":"10.1016\/j.ajpath.2013.12.004_bib18","doi-asserted-by":"crossref","first-page":"e51387","DOI":"10.1371\/journal.pone.0051387","article-title":"Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b","volume":"7","author":"Mantri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2013.12.004_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/infdis\/168.5.1157","article-title":"Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine","volume":"168","author":"Bagasra","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2013.12.004_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/13550280701528684","article-title":"Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia","volume":"13","author":"Dhillon","year":"2007","journal-title":"J Neurovirol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1189\/jlb.0405219","article-title":"Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model","volume":"78","author":"Roth","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib22","article-title":"Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression","author":"Manti","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.56036","article-title":"Cocaine: plasma concentrations after intranasal application in man","volume":"191","author":"Van Dyke","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.12.004_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1874143600802010070","article-title":"Mechanisms of acute cocaine toxicity","volume":"2","author":"Heard","year":"2008","journal-title":"Open Pharmacol J"},{"key":"10.1016\/j.ajpath.2013.12.004_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/ajem.2000.9282","article-title":"Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED","volume":"18","author":"Blaho","year":"2000","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.1984.03350140035021","article-title":"Death caused by recreational cocaine use: an update","volume":"252","author":"Mittleman","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2013.12.004_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1520\/JFS16087J","article-title":"Relating cocaine blood concentrations to toxicity: an autopsy study of 99 cases","volume":"43","author":"Karch","year":"1998","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.ajpath.2013.12.004_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0379-0738(90)90105-8","article-title":"Cocaine fatality: an unexplained blood concentration in a fatal overdose","volume":"48","author":"Peretti","year":"1990","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.ajpath.2013.12.004_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4690-1-12","article-title":"Apoptosis of uninfected cells induced by HIV envelope glycoproteins","volume":"1","author":"Ahr","year":"2004","journal-title":"Retrovirology"},{"key":"10.1016\/j.ajpath.2013.12.004_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nm0295-129","article-title":"Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes","volume":"1","author":"Finkel","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/362359a0","article-title":"Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS","volume":"362","author":"Embretson","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.12.004_bib32","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1128\/jvi.69.11.6925-6931.1995","article-title":"Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells","volume":"69","author":"Heinkelein","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1\u2013infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib34","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1128\/JVI.77.10.5846-5854.2003","article-title":"In\u00a0vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells","volume":"77","author":"Jekle","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib35","first-page":"2","article-title":"Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation","volume":"18","author":"Lane","year":"2010","journal-title":"Top HIV Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib37","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1074\/jbc.273.19.11944","article-title":"Molecular ordering in HIV-induced apoptosis: oxidative stress, activation of caspases, and cell survival are regulated by transaldolase","volume":"273","author":"Banki","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.12.004_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002030-199701000-00004","article-title":"Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome","volume":"11","author":"Cossarizza","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/15230860050192323","article-title":"Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease","volume":"2","author":"Perl","year":"2000","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ajpath.2013.12.004_bib40","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.162.3.1466","article-title":"Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling","volume":"162","author":"Banki","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0167-5699(94)90018-3","article-title":"Oxidative stress as a mediator of apoptosis","volume":"15","author":"Buttke","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.ajpath.2013.12.004_bib42","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1074\/jbc.M507867200","article-title":"Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms","volume":"281","author":"Pandhare","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.12.004_bib43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/apc.2008.0022","article-title":"Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast","volume":"22","author":"Pence","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib44","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0b013e32830507f2","article-title":"Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women","volume":"22","author":"Cook","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.1989.03420040099027","article-title":"Cocaine use and HIV infection in intravenous drug users in San Francisco","volume":"261","author":"Chaisson","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2013.12.004_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/oxfordjournals.aje.a116021","article-title":"New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1","volume":"134","author":"Anthony","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.lfs.2011.01.003","article-title":"Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission","volume":"88","author":"Cook","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.ajpath.2013.12.004_bib48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1574-695X.2006.00097.x","article-title":"Addictive drugs and their relationship with infectious diseases","volume":"47","author":"Friedman","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/aid.2010.0086","article-title":"Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression","volume":"27","author":"Rafie","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ajpath.2013.12.004_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/clin.1994.1036","article-title":"Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine","volume":"70","author":"Ruiz","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00230-0","article-title":"In\u00a0vivo effects of cocaine on immune cell function","volume":"83","author":"Pellegrino","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/08923979909007140","article-title":"Effect of short-term cocaine administration on the immune system of young and old C57BL\/6 female mice","volume":"21","author":"Colombo","year":"1999","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)21295-2","article-title":"Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects","volume":"279","author":"Evans","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2013.12.004_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jat\/26.7.382","article-title":"Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration","volume":"26","author":"Jenkins","year":"2002","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jat\/22.6.435","article-title":"Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use","volume":"22","author":"Jufer","year":"1998","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/clin.1998.4579","article-title":"Peripheral human T lymphocyte maintenance of immune functional capacity and phenotypic characteristics following in\u00a0vivo cocaine exposure","volume":"88","author":"Ruiz","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbi.2008.07.010","article-title":"Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy","volume":"22","author":"Carrico","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ajpath.2013.12.004_bib58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1189\/jlb.1112566","article-title":"Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection","volume":"94","author":"Kim","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib59","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00002030-200207260-00003","article-title":"CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells","volume":"16","author":"Algeciras-Schimnich","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2013.12.004_bib60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.187.5.711","article-title":"CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis","volume":"187","author":"Algeciras","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2013.12.004_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/viro.2001.1266","article-title":"The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells","volume":"292","author":"Arthos","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.ajpath.2013.12.004_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/13550280902755375","article-title":"Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways","volume":"15","author":"Yao","year":"2009","journal-title":"J Neurovirol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.neuropharm.2005.01.018","article-title":"Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures","volume":"48","author":"Dietrich","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajpath.2013.12.004_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/529T2WDNEB6X8VUN","article-title":"Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen","volume":"122","author":"Barletta","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajpath.2013.12.004_bib65","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2741\/2162","article-title":"Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women","volume":"12","author":"Duncan","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajpath.2013.12.004_bib66","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/168.6.1490","article-title":"Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections","volume":"168","author":"Niu","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajpath.2013.12.004_bib67","unstructured":"The CDC MMWR Morb Mortal Wkly Rep,\u00a0June 21, 2013."}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:04:08Z","timestamp":1762081448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0002944014000091"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.004","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocaine Enhances HIV-1\u2013Induced CD4+ T-Cell Apoptosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}